In a small study, 1 in 3 prostate cancer patients who underwent salvage robotic-assisted radical prostatectomy following partial ablation with high-intensity focused ultrasound required adjuvant radiation or androgen deprivation therapy within 12 months.
In a study of men on active surveillance for low-risk prostate cancer, multiparametric magnetic resonance imaging by itself missed about one-fifth of men who had pathologic upgrading on subsequent biopsies.
Use of a gonadotropin-releasing hormone antagonist is associated with lower risks for death than GnRH agonists, a systematic review and meta-analysis found.
Research findings from ESMO confirm that patients with cancer can improve their symptoms of CRF if they “avoid inactivity”; in addition, greater use of supportive care can also help.
